Please login to the form below

Not currently logged in

Aurobindo/ Diod generic venture in Russia

Aurobindo and Diod have established a joint venture to manufacture and sell generic pharmaceuticals in the markets of Russia, Belarus and Kazakhstan

Aurobindo Pharma and Ojsc Diod, a Russian manufacturer of ecological healthcare equipment and nutrition supplements, have announced a joint venture called the Aurospharma Company, which is to be established in Russia and will manufacture and sell generic pharmaceuticals in the markets of Russia, Belarus and Kazakhstan.

As part of this venture, Aurospharma intends to construct a state of the art plant in order to manufacture various drugs, mainly ones classified as over the counter (OTC) products in Russia. This includes non penicillin and non cephalosporin Rx generics. In addition, drugs such as penicillin and cephalosporins will also be sourced, in order to sell.

The plant to be built in Russia will focus on the production of socially significant medicinal drugs, therefore complying with the Strategy for Development of the Russian pharmaceutical industry. It will enable the Russian public healthcare system to be less dependent on the importing of finished dosage form, therefore creating substantial savings and making modern pharmaceuticals more affordable and accessible to the public within those countries.

It is expected that the construction will be completed and the plant will attain its rated capacity closer to the end of 2013.

8th September 2011


Featured jobs

Subscribe to our email news alerts


Add my company

Accession was a born from a passion and a vision. A passion to harness the power of market access to...

Latest intelligence

Advancing women in healthcare
Fostering the next generation of leaders...
The Challenges Of UX In Healthcare: Technology To Change Lives
Blue Latitude Health Director and Head of Customer Experience Elisa Del Galdo explores the latest digital healthcare trends and reveals the innovations changing the sector today....
It’s all about patient outcomes… right?
Lessons from history: a design thinking perspective...